BioSyntech
BioSyntech announces conditional approval for listing on the Toronto Stock Exchange
Published in Health Business Week, November 3rd, 2006
In making this announcement at the annual meeting of shareholders, Claude LeDuc, president and CEO of BioSyntech, stated: "This achievement, which was made possible by our recent financing, marks another important milestone for BioSyntech. We have already assembled a team of highly talented and experienced executives and secured the financial resources to accomplish our objectives. In addition, we will be in the clinical stage with our three lead products before the end of the current fiscal year, and have...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
Source: Health Business Week (2006-11-03)
More Articles from Health Business Week
- Acorda Therapeutics
Acorda Therapeutics announces $31.5 million financing - Avant Immunotherapeutics
Avant signs agreement with Pfizer to develop animal health vaccines - Business Update
UnitedHealthcare, United Resource Networks sign multiyear agreement with Wisconsin groups - Clarient
Clarient announces $5 million financing agreement with GE Healthcare Financial Services - Continucare
Continucare completes acquisition of Miami Dade Health Centers - Criticare Systems
Criticare Systems, Inc. reports results for fourth quarter and fiscal 2006 year end - More from this issue of Health Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
